Page last updated: 2024-08-23

tetrahydrocannabivarin 9 and Muscle Contraction

tetrahydrocannabivarin 9 has been researched along with Muscle Contraction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baillie, G; Pertwee, RG; Price, MR; Ross, RA; Stevenson, LA; Thomas, A; Wease, KN	1
Lichtman, AH; Martin, BR; Pertwee, RG; Razdan, RK; Ross, RA; Stevenson, LA; Thomas, A; Varvel, SA	1

Other Studies

2 other study(ies) available for tetrahydrocannabivarin 9 and Muscle Contraction

Article	Year
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. British journal of pharmacology, 2005, Volume: 146, Issue:7 Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cannabis; CHO Cells; Clonidine; Cricetinae; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mice; Morpholines; Muscle Contraction; Naphthalenes; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Vas Deferens	2005
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo. British journal of pharmacology, 2007, Volume: 150, Issue:5 Topics: Analgesics, Non-Narcotic; Animals; Benzoxazines; Binding, Competitive; Body Temperature; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Locomotion; Male; Mice; Mice, Inbred ICR; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Pain Measurement; Pain Threshold; Phenols; Protein Binding; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Vas Deferens	2007

Article

Year

Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.

British journal of pharmacology, 2005, Volume: 146, Issue:7

Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cannabis; CHO Cells; Clonidine; Cricetinae; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mice; Morpholines; Muscle Contraction; Naphthalenes; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Vas Deferens

2005

The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.

British journal of pharmacology, 2007, Volume: 150, Issue:5

Topics: Analgesics, Non-Narcotic; Animals; Benzoxazines; Binding, Competitive; Body Temperature; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Locomotion; Male; Mice; Mice, Inbred ICR; Morpholines; Muscle Contraction; Muscle, Smooth; Naphthalenes; Pain Measurement; Pain Threshold; Phenols; Protein Binding; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Vas Deferens

2007